{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:35:45Z","timestamp":1774438545870,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.medmal.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:53:39Z","timestamp":1412996019000},"page":"530-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use"],"prefix":"10.1016","volume":"44","author":[{"given":"R.","family":"Lepeule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Leflon-Guibout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vanjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-R.","family":"Zahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Besson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.medmal.2014.09.004_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"10.1016\/j.medmal.2014.09.004_bib0010","doi-asserted-by":"crossref","first-page":"20525","DOI":"10.2807\/1560-7917.ES2013.18.28.20525","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013","volume":"18","author":"Glasner","year":"2013","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.medmal.2014.09.004_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"Schito","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.medmal.2014.09.004_bib0020","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.7326\/0003-4819-149-1-200807010-00009-w1","article-title":"Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"149","author":"Lin","year":"2008","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1 (1)","key":"10.1016\/j.medmal.2014.09.004_bib0025","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijantimicag.2006.05.010","article-title":"Asymptomatic bacteriuria: review and discussion of the IDSA guidelines","volume":"28","author":"Nicolle","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.medmal.2014.09.004_bib0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2014.09.004_bib0035","series-title":"Diagnostic et antibioth\u00e9rapie des infections urinaires bact\u00e9riennes communautaires chez l\u2019adulte. Recommandations de bonne pratique","author":"AFSSAPS","year":"2008"},{"issue":"5","key":"10.1016\/j.medmal.2014.09.004_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2014.09.004_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/593951","article-title":"Importance of urinary tract infection to antibiotic use among hospitalized patients","volume":"30","author":"Gandhi","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.medmal.2014.09.004_bib0050","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/597403","article-title":"Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital","volume":"48","author":"Cope","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.medmal.2014.09.004_bib0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1086\/660764","article-title":"Electronic memorandum decreases unnecessary antimicrobial use for asymptomatic bacteriuria and culture-negative pyuria","volume":"32","author":"Linares","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.medmal.2014.09.004_bib0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1016\/j.medmal.2014.09.004_bib0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/598244","article-title":"Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns","volume":"30","author":"Hussein","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.medmal.2014.09.004_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/mdr.2005.11.165","article-title":"Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients","volume":"11","author":"Kwak","year":"2005","journal-title":"Microb Drug Resist"},{"issue":"3","key":"10.1016\/j.medmal.2014.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.01823-12","article-title":"Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients","volume":"57","author":"Armand-Lefevre","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.medmal.2014.09.004_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"beta-Lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2014.09.004_bib0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/cid\/cis916","article-title":"Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters","volume":"56","author":"Lee","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2014.09.004_bib0090","first-page":"3","article-title":"Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15 type extended-spectrum beta-lactamase","volume":"2012","author":"Lepeule","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.medmal.2014.09.004_bib0095","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","article-title":"The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"17","author":"Doi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2014.09.004_bib0100","first-page":"28","article-title":"Treatment of pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in children","volume":"2012","author":"Katsuta","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2014.09.004_bib0105","series-title":"24th European Congress of Clinical Microbiology and Infectious Diseases","article-title":"Clinical and microbiological outcomes after cefoxitin treatment for infections caused by extended-spectrum-beta-lactmase-producing Enterobacteriaceae: results of an observationnal study","author":"Kerneis","year":"2014"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1400239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1400239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:12:58Z","timestamp":1759972378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X1400239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":21,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0399077X1400239X"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2014.09.004","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}